The reduction of CCL-17 suggests that the reduction of M2 macrophages in emphysema is mainly dominated by the M2a subtype, and the reduction of the M2a subtype in turn stimulates the increase of IL-13 and IL-4, and also leads to a decrease in anti-inflammatory capacity. The gene discussed is CCL17; the disease is pulmonary emphysema.